Posted on 5月 10, 20235/10/23
Navigating an Ever-evolving Canadian Market Access and Reimbursement Environment
Posted on 5月 9, 20235/9/23
From Limitations to Expansions: How Prioritizing Patients’ Speed to Therapy Drives Therapy Adoption
Posted on 4月 21, 20234/21/23
Left-Right-Left: The Latest in Pharma-Payer Ping Pong
Posted on 4月 20, 20234/20/23
Your Guide to Developing a Best-in-Class Specialty Pharmacy Network Strategy
Posted on 4月 18, 20234/18/23
Employ an Integrated Market Access Strategy to Deliver Brand Success
Posted on 4月 17, 20234/17/23
What EVERSANA’s Growing Abstract Count at ISPOR U.S. Means to the HEOR Industry
Posted on 4月 13, 20234/13/23
Peeking Behind the PBM-lead GPO Curtain
Posted on 4月 11, 20234/11/23
Elevating Field Reimbursement Manager Performance through Insights & Comparative Data
Posted on 4月 6, 20234/6/23